CRL vs DEVS · rev $4.05B vs rev $25.8K
Charles River Laboratories (CRL) versus DevvStream Corp. Common Stock (DEVS) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
CRL currently screens at market cap $7.78B. DEVS currently screens at market cap $13.4M.
Not investment advice. Open the CRL and DEVS stock pages for the full models.
Not investment advice.